1. Mitchell, Amanda C, Jiang, Yan, Peter, Cyril, Akbarian, Schahram. 2014. Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia. In Schizophrenia research, 167, 28-34. doi:10.1016/j.schres.2014.10.020. https://pubmed.ncbi.nlm.nih.gov/25458568/
2. Huang, De, Wang, Yan, Thompson, J Will, Li, Qi-Jing, Wang, Xiao-Fan. 2022. Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression. In Nature cell biology, 24, 230-241. doi:10.1038/s41556-021-00820-9. https://pubmed.ncbi.nlm.nih.gov/35145222/
3. Bruxel, Estela M, Akutagava-Martins, Glaucia C, Salatino-Oliveira, Angélica, Rohde, Luis A, Hutz, Mara H. 2016. GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit/Hyperactivity Disorder. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 171, 1099-1104. doi:10.1002/ajmg.b.32489. https://pubmed.ncbi.nlm.nih.gov/27530595/
4. Arrúe, Aurora, González-Torres, Miguel Angel, Basterreche, Nieves, Catalán, Ana, Zumárraga, Mercedes. 2019. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels. In Neurochemistry international, 124, 152-161. doi:10.1016/j.neuint.2019.01.004. https://pubmed.ncbi.nlm.nih.gov/30625343/
5. Gerhard, Danielle M, Pothula, Santosh, Liu, Rong-Jian, Wohleb, Eric S, Duman, Ronald S. . GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions. In The Journal of clinical investigation, 130, 1336-1349. doi:10.1172/JCI130808. https://pubmed.ncbi.nlm.nih.gov/31743111/
6. Wan, Lilin, Liu, Yifan, Liu, Ruiji, Mao, Weipu. 2023. GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer. In Cancer cell international, 23, 255. doi:10.1186/s12935-023-03093-4. https://pubmed.ncbi.nlm.nih.gov/37904122/
7. Kirenskaya, Anna V, Storozheva, Zinaida I, Gruden, Marina A, Sewell, Robert D E. 2018. COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients. In European archives of psychiatry and clinical neuroscience, 268, 571-584. doi:10.1007/s00406-018-0881-7. https://pubmed.ncbi.nlm.nih.gov/29429137/